Wealth Alliance Advisory Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1735734 Wichita, KS

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$296,267

-$21,775 QoQ

Shares Held

2,345

+2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#1,656

of 2,266 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wealth Alliance Advisory Group, LLC holds $19,374,550 across 10 Drug Manufacturers - General names. GILD ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,285	$7,538,418
2	JNJ	Johnson & Johnson	14,937	$3,793,549
3	ABBV	AbbVie Inc.	11,481	$2,889,078
4	AMGN	Amgen Inc	5,753	$2,083,276
5	MRK	Merck & Co., Inc.	8,319	$1,068,991
6	BMY	Bristol Myers Squibb Co	15,689	$904,000
7	NVS	Novartis AG	2,100	$329,112
8	GILD	Gilead Sciences, Inc. This page	2,345	$296,267

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$296,267	2,345	+2.8%	Shares	Sole	2026-07-23
2026-03-31	$318,042	2,282	+0.2%	Shares	Sole	2026-04-09
2025-12-31	$279,478	2,277	-4.4%	Shares	Sole	2026-01-29
2025-09-30	$264,402	2,382	0.0%	Shares	Sole	2025-10-14
2025-06-30	$264,092	2,382	0.0%	Shares	Sole	2025-07-07
2025-03-31	$266,903	2,382	0.0%	Shares	Sole	2025-04-10
2024-12-31	$220,025	2,382	-1.7%	Shares	Sole	2025-01-15
2023-03-31	$201,036	2,423	-5.3%	Shares	Sole	2023-05-02
2022-12-31	$219,604	2,558	-25.3%	Shares	Sole	2023-01-17
2022-09-30	$211,164	3,423	-15.6%	Shares	Sole	2022-10-12
2022-03-31	$241,248	4,058	-1.5%	Shares	Sole	2022-04-18
2021-12-31	$299,080	4,119	0.0%	Shares	Sole	2022-01-13
2021-09-30	$287,712	4,119	0.0%	Shares	Sole	2021-10-08
2021-06-30	$283,634	4,119	0.0%	Shares	Sole	2021-07-13
2021-03-31	$266,210	4,119	+48.8%	Shares	Sole	2021-04-28
2020-03-31	$206,935	2,768	—	Shares	Sole	2020-04-15
No filing history on record for this holder in this stock.